Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kaye

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Nutrients|April 14, 2026
Dietary Management After Ulcerative Colitis Surgery: A Thematic Analysis of TikTok ContentOliver R Kaye, Dakota R Rhys-Jones, Orestis Argyriou, et al.
Cancer Causes & Control : CCC|March 29, 2025
Socioeconomic disparities: a more important risk factor for advanced-stage oral cancer in Florida than smoking?Garrett Forman, Uche C Ezeh, Isabella Buitron, et al.
JCO Oncology Practice|June 17, 2021
Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell CarcinomaStephanie B Wheeler, Lisa P Spees, Bradford E Jackson, et al.
Urologic Oncology|February 26, 2023
Use of a physical activity monitor to track perioperative activity of radical cystectomy patients. Our first glimpse at what our patients are doing before and after surgeryAlex Zhu, Joel E Berends, Stephanie Daignault-Newton, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2017
Thoughtflow: Standards and Tools for Provenance Capture and Workflow Definition to Support Model-Informed Drug Discovery and DevelopmentJ J Wilkins, Pls Chan, J Chard, et al.
Cancer Medicine|September 4, 2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinomaLisa P Spees, Stephanie B Wheeler, Bradford E Jackson, et al.
Journal of Geriatric Oncology|February 7, 2022
Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinomaDeborah R Kaye, Lauren E Wilson, Melissa A Greiner, et al.
Clinical Genitourinary Cancer|May 20, 2022
Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer AgentsLisa P Spees, Michaela A Dinan, Bradford E Jackson, et al.
JCO Oncology Practice|November 22, 2022
End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer TherapyHannah E Dzimitrowicz, Lauren E Wilson, Bradford E Jackson, et al.
Urology|August 3, 2020
The Feasibility and Impact of a Presurgical Exercise Intervention Program (Prehabilitation) for Patients Undergoing Cystectomy for Bladder CancerDeborah R Kaye, Christine Schafer, Steven Thelen-Perry, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Nutrients|April 14, 2026
Dietary Management After Ulcerative Colitis Surgery: A Thematic Analysis of TikTok ContentOliver R Kaye, Dakota R Rhys-Jones, Orestis Argyriou, et al.
Cancer Causes & Control : CCC|March 29, 2025
Socioeconomic disparities: a more important risk factor for advanced-stage oral cancer in Florida than smoking?Garrett Forman, Uche C Ezeh, Isabella Buitron, et al.
JCO Oncology Practice|June 17, 2021
Patterns and Predictors of Oral Anticancer Agent Use in Diverse Patients With Metastatic Renal Cell CarcinomaStephanie B Wheeler, Lisa P Spees, Bradford E Jackson, et al.
Urologic Oncology|February 26, 2023
Use of a physical activity monitor to track perioperative activity of radical cystectomy patients. Our first glimpse at what our patients are doing before and after surgeryAlex Zhu, Joel E Berends, Stephanie Daignault-Newton, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2017
Thoughtflow: Standards and Tools for Provenance Capture and Workflow Definition to Support Model-Informed Drug Discovery and DevelopmentJ J Wilkins, Pls Chan, J Chard, et al.
Cancer Medicine|September 4, 2021
Provider- and patient-level predictors of oral anticancer agent initiation and adherence in patients with metastatic renal cell carcinomaLisa P Spees, Stephanie B Wheeler, Bradford E Jackson, et al.
Journal of Geriatric Oncology|February 7, 2022
Patient, provider, and hospital factors associated with oral anti-neoplastic agent initiation and adherence in older patients with metastatic renal cell carcinomaDeborah R Kaye, Lauren E Wilson, Melissa A Greiner, et al.
Clinical Genitourinary Cancer|May 20, 2022
Patient- And Provider-Level Predictors of Survival Among Patients With Metastatic Renal Cell Carcinoma Initiating Oral Anticancer AgentsLisa P Spees, Michaela A Dinan, Bradford E Jackson, et al.
JCO Oncology Practice|November 22, 2022
End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer TherapyHannah E Dzimitrowicz, Lauren E Wilson, Bradford E Jackson, et al.
Urology|August 3, 2020
The Feasibility and Impact of a Presurgical Exercise Intervention Program (Prehabilitation) for Patients Undergoing Cystectomy for Bladder CancerDeborah R Kaye, Christine Schafer, Steven Thelen-Perry, et al.
Pageof 15